Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1996Transplantation

Half Dose of Okt3 Is Efficient in Treatment of Steroid-Resistant Renal Allograft Rejection

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKarsten MidtvedtNasjonalforeningen for FolkehelsenATAnne Beate TafjordAHAnders HartmannOslo University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Midtvedt et al. (1996) studied this question.

synapsesocial.com/papers/6a890e2003fab2a419a5ed36https://doi.org/10.1097/00007890-199607150-00008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE MECHANISM OF ANTI-CD3 MONOCLONAL ANTIBODIES1990 · 51 citations
  2. 2TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY1981 · 395 citations
  3. 3INHIBITION OF ANTI-OKT3 ANTIBODY GENERATION BY CYCLOSPORINE—RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL1990 · 43 citations
  4. 4Standard versus low‐dose OKT3 induction therapy of cadaveric renal transplants: Comparison of outcome data versus OKT3 dose and serum levels1992 · 13 citations
  5. 5COMPARISON OF OKT3 WITH ALG FOR PROPHYLAXIS FOR PATIENTS WITH ACUTE RENAL FAILURE AFTER CADAVERIC RENAL TRANSPLANTATION1991 · 25 citations